Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority to HN2010000739ApriorityCriticalpatent/HN2010000739A/en
Publication of HN2010000739ApublicationCriticalpatent/HN2010000739A/en
LA PRESENTE INVENCION SE REFIERE A LOS COMPUESTOS DE LA FORMULA I: EN DONDE Z,X,J,R2 Y W SE DESCRIBAN EN LA ESPECIFICACION, ASI COMO LOS SOLVATOS,HIDRATOS,TAUTOMEROS,Y SALES FARMACEUTICAMENTE ACEPTABLES DE ESTOS QUE INHIBEN LAS PROTEINAS TIROSINA QUINASAS, ESPECIALMENTE LA QUINASAC-FMSTHE PRESENT INVENTION REFERS TO THE COMPOUNDS OF FORMULA: WHERE Z, X, J, R2 AND W ARE DESCRIBED IN THE SPECIFICATION, AS WELL AS SOLVATES, HYDRAPTS, TAUTOMERS, AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THOSE THAT INHIBIT THE PROTEINAS , ESPECIALLY THE QUINASAC-FMS